Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 OmniComm, Veeda in Preferred Program Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

OmniComm, Veeda in Preferred Program Pact

Will run first study using the TrialMaster EDC suite

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Veeda Clinical Research has joined OmniComm Systems CRO Preferred Program, and has signed an agreement to run its first study. The Phase I oncology trial will use the TrialMaster EDC suite to manage data collection, submission, and medical coding needs. The CRO program offers a dedicated, hosted environment, sales and marketing support, as well as training.
 
“We specifically selected TrialMaster due to their experience and expertise in conducting Oncology trials,” said Sharon Jameson, vice president of Global Clinical Operations. “We are also pleased to have OmniComm as a strategic partner and look forward to working with them on mutual projects in the future.”
 
“We look forward to working with this highly specialized CRO,” said Stephen Johnson, president and chief operating officer of OmniComm Systems. “We have a tremendous amount of oncology experience and our TrialMaster solution is especially suited for these types of complex studies.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters